Literature DB >> 16108031

Transplantation of chondrocytes seeded on collagen-based scaffold in cartilage defects in rabbits.

Luciana De Franceschi1, Brunella Grigolo, Livia Roseti, Andrea Facchini, Milena Fini, Gianluca Giavaresi, Matilde Tschon, Roberto Giardino.   

Abstract

Recent success in tissue engineering by restoring cartilage defects by transplanting autologous chondrocyte cells on a three-dimensional scaffold has prompted the improvement of this therapeutic strategy. Here we describe a new approach investigating the healing of rabbit cartilage by means of autologous chondrocytes seeded on a biomaterial made of an equine collagen type I-based scaffold. Full-thickness defects were created bilaterally in the weight-bearing surface of the medial femoral condyle of both femora of New Zealand male rabbits. The wounds were then repaired by using both chondrocytes seeded on the biomaterial and biomaterial alone. Controls were similarly treated but received either no treatment or implants of the delivery substance. Histological examination of the reconstructed tissues at 1, 3, 6, and 12 months after transplantation showed that at 1 and 3 months there was no formation of reconstructed tissue in any of the groups evaluated; after 6 months there was evidence of a newly regenerated tissue with some fibrocartilaginous features only in the group treated with biomaterial-seeded cells, and at 12 months a more organized tissue was evident in the same group. With regards to the group transplanted with biomaterial alone and the untreated control group, there was no evidence of new tissue production. These results advocate the use of this collagen-based scaffold for further in vivo studies on large size animals and, finally, in human clinical trials for the treatment of knee cartilage defects. (c) 2005 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2005        PMID: 16108031     DOI: 10.1002/jbm.a.30471

Source DB:  PubMed          Journal:  J Biomed Mater Res A        ISSN: 1549-3296            Impact factor:   4.396


  7 in total

Review 1.  Protein based therapeutic delivery agents: Contemporary developments and challenges.

Authors:  Liming Yin; Carlo Yuvienco; Jin Kim Montclare
Journal:  Biomaterials       Date:  2017-04-21       Impact factor: 12.479

Review 2.  Engineering cartilage tissue.

Authors:  Cindy Chung; Jason A Burdick
Journal:  Adv Drug Deliv Rev       Date:  2007-10-05       Impact factor: 15.470

Review 3.  Success rates and immunologic responses of autogenic, allogenic, and xenogenic treatments to repair articular cartilage defects.

Authors:  Christopher M Revell; Kyriacos A Athanasiou
Journal:  Tissue Eng Part B Rev       Date:  2009-03       Impact factor: 6.389

4.  Repair of articular cartilage defects in rabbits through tissue-engineered cartilage constructed with chitosan hydrogel and chondrocytes.

Authors:  Ming Zhao; Zhu Chen; Kang Liu; Yu-qing Wan; Xu-dong Li; Xu-wei Luo; Yi-guang Bai; Ze-long Yang; Gang Feng
Journal:  J Zhejiang Univ Sci B       Date:  2015-11       Impact factor: 3.066

5.  Tissue Engineering of Cartilage Using Collagen Scaffold Enriched with Plant Polysaccharides.

Authors:  K Uday Chandrika; Sapna Kacha; Anuja S Nair; Vijayishwer S Jamwal; Shruti Sandilya; Shashi Singh
Journal:  Cartilage       Date:  2021-04-27       Impact factor: 3.117

6.  In vitro and in vivo studies of a novel bacterial cellulose-based acellular bilayer nanocomposite scaffold for the repair of osteochondral defects.

Authors:  Jyoti V Kumbhar; Sachin H Jadhav; Dhananjay S Bodas; Amruta Barhanpurkar-Naik; Mohan R Wani; Kishore M Paknikar; Jyutika M Rajwade
Journal:  Int J Nanomedicine       Date:  2017-09-01

7.  Hyaluronan production and chondrogenic properties of primary human chondrocyte on gelatin based hematostatic spongostan scaffold.

Authors:  Jeerawan Klangjorhor; Puwapong Nimkingratana; Jongkolnee Settakorn; Dumnoensun Pruksakorn; Taninnit Leerapun; Olarn Arpornchayanon; Sattaya Rojanasthien; Prachya Kongtawelert; Peraphan Pothacharoen
Journal:  J Orthop Surg Res       Date:  2012-12-19       Impact factor: 2.359

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.